Fosamax Judge Tosses Leftover Class Action Claims

Law360, New York (January 29, 2008, 12:00 AM EST) -- The federal judge presiding over the Fosamax case has dismissed a host of claims connected to a push for a dental monitoring class in the multidistrict litigation that centers around whether Merck & Co.'s osteoporosis medication leads to painful deterioration of the jaw.

U.S. District Judge John Keenan bounced with prejudice Monday the remaining class claims connected to a quartet of suits that had been seeking certification for the medical monitoring of patients who had yet to develop osteonecrosis.

Earlier this month, Judge Keenan batted down...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.